Medications

Gilead buys US pharma rival Pharmasset

US biotech firm Gilead Sciences announced plans Monday to acquire rival Pharmasset, a group specializing in treatments for AIDS and hepatitis, for $11 billion.

Diseases, Conditions, Syndromes

Combination of oral drugs suppresses common type of hepatitis C

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

Diseases, Conditions, Syndromes

Sofosbuvir-velpatasvir successful in hep C regardless of genotype

(HealthDay)—Sofosbuvir-velpatasvir is effective for hepatitis C virus (HCV), regardless of genotype, according to three studies published online Nov. 17 in the New England Journal of Medicine. The research was published ...

Diseases, Conditions, Syndromes

Study reveals prehistoric journey of hepatitis B

(Medical Xpress)—A new study has revealed how the spread of hepatitis B coincides with dates of human migration throughout history, starting around 40 000 years ago. The study could provide a framework for studying the ...

Diseases, Conditions, Syndromes

Study finds specific gene linked to cold sore susceptibility

Investigators have identified a human chromosome containing a specific gene associated with susceptibility to herpes simplex labialis (HSL), the common cold sore. Published in the Journal of Infectious Diseases and now available ...

page 4 from 17